​
​

TScan Therapeutics (TCRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

TScan Therapeutics Revenue Highlights

Latest Revenue (Y)

$21.05M

0

TScan Therapeutics Revenue by Period

TScan Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$21.05M55.52%
2022-12-31$13.54M33.47%
2021-12-31$10.14M834.65%
2020-12-31$1.08M100.00%
2019-12-31--

TScan Therapeutics generated $21.05M in revenue during NA 2023, up 55.52% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

TScan Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$566.00K-92.15%
2023-12-31$7.21M85.52%
2023-09-30$3.89M23.48%
2023-06-30$3.15M-53.73%
2023-03-31$6.80M680200.00%
2022-12-31$1.00K-99.97%
2022-09-30$3.36M-17.09%
2022-06-30$4.06M34.26%
2022-03-31$3.02M5.85%
2021-12-31$2.85M18.33%
2021-09-30$2.41M-15.31%
2021-06-30$2.85M40.50%
2021-03-31$2.03M154.97%
2020-12-31$795.00K174.14%
2020-09-30$290.00K100.00%
2020-06-30-100.00%
2020-03-31--

TScan Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

TScan Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$366.28M$176.57M
ARWRArrowhead Pharmaceuticals$240.74M-
VECTVectivBio$27.34M$676.00K
TCRXTScan Therapeutics$21.05M-
ITOSiTeos Therapeutics$12.60M$35.00M
PRQRProQR Therapeutics$6.38M$4.48M
CUECue Biopharma$5.49M$3.34M
TFFPTFF Pharmaceuticals$733.87K$193.39K
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
CGTXCognition Therapeutics--
ANNXAnnexon--
TERNTerns Pharmaceuticals--
DRMADermata Therapeutics--

TCRX Revenue FAQ

What is TScan Therapeutics’s yearly revenue?

TScan Therapeutics's yearly revenue for 2023 was $21.05M, representing an increase of 55.52% compared to 2022. The company's yearly revenue for 2022 was $13.54M, representing an increase of 33.47% compared to 2021. TCRX's yearly revenue for 2021 was $10.14M, representing an increase of 834.65% compared to 2020.

What is TScan Therapeutics’s quarterly revenue?

TScan Therapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $566K, a -92.15% decrease from the previous quarter (Q4 2023), and a -91.68% decrease year-over-year (Q1 2023). TCRX's quarterly revenue for Q4 2023 was $7.21M, a 85.52% increase from the previous quarter (Q3 2023), and a 721000.00% increase year-over-year (Q4 2022).

What is TScan Therapeutics’s revenue growth rate?

TScan Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 107.56%, and for the last 5 years (2019-2023) was 0%.